Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Helen of Troy
HELE
$656M
| $18.1M | 0.01% |
302,709
+100,767
| +50% | +$6.7M |
|
602
U-Haul Holding Co Series N
UHAL.B
$12.4B
| $18.1M | 0.01% |
281,853
+4,335
| +2% | +$285K |
|
603
Rush Enterprises Class A
RUSHA
$6.34B
| $18M | 0.01% |
329,027
+20,823
| +7% | +$1.19M |
|
604
Quaker Houghton
KWR
$2.58B
| $18M | 0.01% |
127,588
+70,218
| +122% | +$11.1M |
|
605
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.66B
| $17.8M | 0.01% |
366,041
-125,614
| -26% | -$6.47M |
|
606
iShares Russell 2000 Value ETF
IWN
$14.3B
| $17.8M | 0.01% |
108,259
-2,639
| -2% | -$450K |
|
607
Jackson Financial
JXN
$8.4B
| $17.7M | 0.01% |
203,071
+138,852
| +216% | +$13.6M |
|
608
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $17.6M | 0.01% |
219,494
-11,743
| -5% | -$959K |
|
609
PDF Solutions
PDFS
$1.72B
| $17.5M | 0.01% |
647,931
-10,616
| -2% | -$320K |
|
610
M/I Homes
MHO
$3.95B
| $17.5M | 0.01% |
131,802
-52,892
| -29% | -$8.32M |
|
611
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $17.4M | 0.01% |
233,028
-69,035
| -23% | -$5.37M |
|
612
Amplitude
AMPL
$1.18B
| $17.4M | 0.01% |
1,645,539
+12,559
| +0.8% | +$126K |
|
|
SPNS
613
DELISTED
Sapiens International
SPNS
| $17.3M | 0.01% |
644,851
+41,422
| +7% | +$1.32M |
|
614
Cal-Maine
CALM
$4.43B
| $17.3M | 0.01% |
167,736
+110,170
| +191% | +$10.4M |
|
615
Kemper
KMPR
$1.81B
| $17M | 0.01% |
256,296
-87,923
| -26% | -$5.8M |
|
|
HEES
616
DELISTED
H&E Equipment Services
HEES
| $17M | 0.01% |
347,475
| – | – |
|
617
Meritage Homes
MTH
$4.78B
| $17M | 0.01% |
221,118
-31,376
| -12% | -$2.86M |
|
618
Yum China
YUMC
$15.7B
| $16.8M | 0.01% |
348,517
+302,512
| +658% | +$14.3M |
|
619
New York Times
NYT
$12.6B
| $16.7M | 0.01% |
321,246
+148,260
| +86% | +$8.09M |
|
620
Cintas
CTAS
$86.6B
| $16.7M | 0.01% |
91,322
+21,015
| +30% | +$4.42M |
|
621
Zimmer Biomet
ZBH
$18.8B
| $16.7M | 0.01% |
157,833
-1,644
| -1% | -$176K |
|
|
ENFN
622
DELISTED
Enfusion, Inc.
ENFN
| $16.6M | 0.01% |
1,615,055
-26,200
| -2% | -$253K |
|
|
DAWN
623
DELISTED
Day One Biopharmaceuticals
DAWN
| $16.6M | 0.01% |
1,306,220
-870,977
| -40% | -$12.1M |
|
624
Axalta
AXTA
$7.45B
| $16.5M | 0.01% |
481,737
+321,279
| +200% | +$12.1M |
|
625
SkinHealth Systems
SKIN
$83.4M
| $16.5M | 0.01% |
10,361,883
-847,525
| -8% | -$1.33M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.